Semaglutide for Weight Loss in India: Price, Brands, Dose, Side Effects & Complete Guide
By Dr. Moxit Shah, DM Endocrinology | Vishuddha Endocrine Clinic, Ahmedabad
Semaglutide is a GLP-1 receptor agonist used in selected people with Type 2 Diabetes and, in appropriate formulations and indications, for chronic weight management. It can reduce appetite, slow gastric emptying and improve glucose regulation. Because multiple semaglutide brands and formulations are now available in India, patients often ask about the price, Indian brands, dose, side effects, safety and which product is appropriate for Weight Loss.
This guide explains the important differences between semaglutide products available in India in 2026. Prices and availability can change, so the figures below are indicative and should be confirmed with a licensed pharmacy before purchase.
What Is Semaglutide?
Semaglutide is a long-acting GLP-1 receptor agonist. It acts on GLP-1 receptors involved in appetite regulation, insulin secretion and glucose control. For chronic weight management, it is used together with a reduced-calorie diet and increased physical activity in people who meet the approved eligibility criteria.
How Does Semaglutide Help With Weight Loss?
Semaglutide can reduce hunger and food intake, increase feelings of fullness and slow the movement of food from the stomach. These effects can make it easier for some people to maintain a calorie deficit. Weight loss varies substantially between individuals and depends on dose, treatment duration, nutrition, activity, sleep, medical conditions and adherence.
Who May Be Considered for Semaglutide for Weight Loss?
For weight-management indications, approved criteria generally include adults with an initial BMI of 30 kg/m² or greater, or BMI of 27 kg/m² or greater in the presence of at least one weight-related medical condition such as Type 2 Diabetes, hypertension or dyslipidemia. The exact indication depends on the specific product and its current Indian regulatory approval.
Semaglutide should not be viewed simply as a cosmetic weight-loss injection. A clinician should assess medical history, BMI, metabolic risk, other medicines and possible contraindications before treatment.
Semaglutide Brands in India in 2026
The Indian semaglutide market changed substantially after patent expiry in March 2026, with multiple domestic manufacturers introducing products. Not every semaglutide brand has the same approved indication, dosage form or device.
| Brand | Company | Form | Key point |
|---|---|---|---|
| Wegovy | Novo Nordisk | Once-weekly injection | Specifically positioned/approved for chronic weight management |
| Ozempic | Novo Nordisk | Once-weekly injection | Semaglutide product primarily indicated for Type 2 Diabetes in India; do not assume it is interchangeable with Wegovy for every patient |
| Rybelsus | Novo Nordisk | Once-daily tablet | Oral semaglutide; diabetes indication rather than automatically a weight-loss prescription |
| Semaglyn | Zydus | Injection/cartridge with reusable pen | Indian semaglutide product with Diabetes and weight-management indications subject to the approved product information |
| Mashema / Alterme | Zydus | Injection/cartridge | Semaglutide brands launched by Zydus |
| Semanext / Livarise | Lupin | Injection | Semaglutide brands marketed by Lupin |
| Semasize / Obesema | Alkem | Injection | Indian semaglutide brands; indication and presentation should be checked on the current label |
| Semanat / Semafull | Natco | Injection | Indian semaglutide products; regulatory indication varies by formulation |
| Noveltreat / Sematrinity | Sun Pharma | Injection | Semaglutide products launched for weight-management and Diabetes indications respectively |
| Obeda | Dr. Reddy’s | Injection | Semaglutide product for Type 2 Diabetes |
| Usema | USV | Injection | Semaglutide product for Type 2 Diabetes |
| Sembolic / Semalix | Torrent | Injection / oral formulation | Semaglutide products; indication depends on the specific formulation |
| GLIPIQ | Glenmark | Injection | Indian semaglutide product; check current approved indication |
Important: This is a representative list, not an exhaustive list of every semaglutide brand in India. Brand availability, pack sizes and regulatory indications can change rapidly. The same active ingredient does not mean that every brand, dose or device can be substituted for another without medical advice.
Semaglutide Price in India: 2026
Semaglutide prices have fallen significantly in India during 2026, but cost varies by brand, formulation, dose, pack size and pharmacy. The following figures are useful as a current reference rather than a guaranteed selling price.
| Product/brand | Indicative current price | Important note |
|---|---|---|
| Wegovy 0.25 mg | About ₹5,660 | Starter strength; current reported MRP |
| Wegovy 0.5 mg | About ₹8,100 | Price increases with strength |
| Wegovy 1 mg | About ₹9,100 | Check current MRP |
| Wegovy 1.7 mg | About ₹12,750 | Check current MRP |
| Wegovy 2.4 mg | About ₹16,400 | Maintenance strength for appropriate patients |
| Ozempic 0.25 mg | About ₹5,660 | Diabetes indication; not automatically equivalent to Wegovy for Weight Loss |
| Rybelsus 3 mg | About ₹2,972 per 10 tablets | Daily tablet; monthly cost depends on prescribed strength |
| Rybelsus 7 mg | About ₹3,300 per 10 tablets | Daily tablet |
| Rybelsus 14 mg | About ₹3,628 per 10 tablets | Daily tablet |
| Indian generic semaglutide brands | Approximately ₹1,300–₹7,500+ depending on product | Prices vary substantially by formulation, company, device and indication |
For example, published September 2026 pharmacy data lists Wegovy at approximately ₹5,660 for 0.25 mg, ₹8,100 for 0.5 mg, ₹9,100 for 1 mg, ₹12,750 for 1.7 mg and ₹16,400 for 2.4 mg. Rybelsus is listed at approximately ₹2,972, ₹3,300 and ₹3,628 per 10-tablet strip for 3 mg, 7 mg and 14 mg respectively. Actual selling prices may differ.
Why Is Generic Semaglutide Cheaper?
After the relevant Indian patent expiry, several Indian manufacturers received approvals and launched semaglutide products. The resulting competition has created a wide range of prices. The lower price does not automatically mean that a product is inferior, but patients should verify that the product is legally marketed, appropriately labelled, stored correctly and dispensed through a licensed pharmacy.
CDSCO records show 2026 approvals for semaglutide formulations from Indian manufacturers, including products with weight-management indications. For example, CDSCO lists semaglutide formulations from Natco and Zydus with chronic weight-management indications in adults meeting specified BMI criteria.
Semaglutide Dose for Weight Loss
Semaglutide for chronic weight management is generally started at a low dose and increased gradually to improve gastrointestinal tolerability. For the Wegovy injection, the usual escalation is:
- 0.25 mg once weekly initially
- 0.5 mg once weekly
- 1 mg once weekly
- 1.7 mg once weekly
- 2.4 mg once weekly as the maintenance dose for appropriate patients
The dose should be increased only according to the prescribed schedule and tolerance. Not every patient needs or can tolerate the maximum dose. Generic products may have different concentrations, devices or titration instructions, so patients should follow the specific product’s prescription and label rather than converting doses themselves.
Common Side Effects of Semaglutide
The most common adverse effects are gastrointestinal and are often more noticeable during dose escalation. They include:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Abdominal discomfort or pain
- Bloating or early fullness
- Headache
Eating smaller meals, avoiding very fatty meals, maintaining adequate hydration and increasing the dose gradually can improve tolerability in many patients.
Important and Serious Side Effects
Although most side effects are manageable, semaglutide can cause clinically important adverse events in some patients. These include:
- Pancreatitis: persistent severe abdominal pain, particularly with vomiting, requires urgent medical assessment.
- Gallbladder disease: gallstones or gallbladder inflammation can occur.
- Dehydration and kidney injury: prolonged vomiting or diarrhea can cause volume depletion.
- Hypoglycemia: the risk increases particularly when semaglutide is combined with insulin or insulin secretagogues.
- Severe gastrointestinal symptoms: some patients can develop significant delayed gastric emptying or gastrointestinal intolerance.
- Diabetic retinopathy complications: people with pre-existing diabetic retinopathy may require appropriate eye monitoring when glucose improves rapidly.
Current prescribing information specifically warns about pancreatitis, gallbladder disease, hypoglycemia with certain diabetes medicines and kidney injury related to volume depletion.
Who Should Not Take Semaglutide?
Semaglutide is not appropriate for everyone. It is contraindicated in people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 for products carrying this contraindication. It should also be avoided in people with a serious previous hypersensitivity reaction to semaglutide or its ingredients.
Pregnancy is another important consideration. Semaglutide for Weight Loss should not be used during pregnancy, and people planning pregnancy should discuss stopping treatment sufficiently in advance with their doctor.
Semaglutide and Thyroid Cancer: What Patients Should Know
The thyroid C-cell tumour warning comes from animal studies. The human relevance of the rodent finding has not been established, but products such as Wegovy carry a contraindication for patients with a personal or family history of medullary thyroid carcinoma or MEN2. This is different from common thyroid conditions such as Hashimoto’s thyroiditis or ordinary hypothyroidism.
Semaglutide and Diabetes
Semaglutide has an important role in Type 2 Diabetes management. Depending on the formulation and approved indication, it can improve HbA1c and reduce body weight. When combined with insulin or certain insulin-secretagogue medicines, the Diabetes regimen may need adjustment to reduce hypoglycemia risk.
See our Diabetes Management Guide for more information.
Semaglutide vs Wegovy vs Ozempic vs Rybelsus
These names can be confusing because several products contain the same active ingredient, semaglutide. The key differences are formulation, dosing, approved indications and device.
- Wegovy: once-weekly injectable semaglutide specifically used for chronic Weight Management in appropriate patients.
- Ozempic: once-weekly injectable semaglutide primarily indicated for Type 2 Diabetes in India.
- Rybelsus: oral semaglutide taken once daily, with a Type 2 Diabetes indication.
- Indian semaglutide brands: several domestic products are now available, but their approved indications, strengths and devices differ.
Can You Switch From One Semaglutide Brand to Another?
Do not switch brands, concentrations or devices simply because another product is cheaper. A cartridge, vial and prefilled pen may have different concentrations and administration instructions. Your doctor should confirm the exact semaglutide dose in milligrams, the concentration and the device before a switch.
Why Buying Semaglutide Online Can Be Risky
Prescription semaglutide should be obtained from a legitimate, licensed pharmacy. Avoid products with unclear labelling, uncertain cold-chain storage, unusually low prices or no requirement for a prescription. The FDA has also reported concerns about unapproved compounded GLP-1 products, including dosing errors and counterfeit products. Although those regulatory concerns are U.S.-specific, the underlying principle of verifying product quality and prescription status is important everywhere.
How Much Weight Can You Lose With Semaglutide?
Weight loss varies from person to person. Clinical trials of semaglutide for chronic weight management have shown substantial average weight reduction in appropriate populations, but individual results can be considerably higher or lower. Treatment should be assessed over time rather than judged from the first few weeks, particularly because the dose is intentionally increased gradually.
What Happens After Stopping Semaglutide?
Semaglutide helps regulate appetite while it is being taken. After stopping treatment, appetite can increase and some weight regain is common. This is one reason Weight Loss treatment should include sustainable eating habits, physical activity, adequate protein and muscle-preserving exercise rather than relying on the medicine alone.
Semaglutide With Diet and Exercise
The medicine works best as part of a broader Weight Loss plan. A practical approach includes adequate protein, vegetables and fibre, sensible portions of carbohydrate-rich foods, resistance training, regular walking or aerobic activity, sufficient sleep and monitoring of weight and waist circumference.
Read our Indian Diet Guide for Weight Loss and our Practical Weight Loss Tips.
Semaglutide for Weight Loss in Ahmedabad
At Vishuddha Endocrine Clinic, Dr. Moxit Shah, DM Endocrinology, evaluates patients for medical Weight Loss treatment, including GLP-1-based therapies, after assessing BMI, metabolic health, medical history, current medicines and treatment goals.
Vishuddha Endocrine Clinic
104-105, Elite Magnum, Bhuyangdev Cross Road, Opp. Utsav Elegance, Vardhmannagar Society, Ghatlodiya/Memnagar, Ahmedabad, Gujarat 380061
Phone / WhatsApp: +91 99799 92797
Frequently Asked Questions
What is the cheapest semaglutide in India?
There is no single permanent cheapest product because generic prices and pack sizes vary. Some Indian semaglutide products are available at substantially lower starting prices than the original brands. However, price should be compared only after confirming the dose, concentration, indication, device and total monthly treatment cost.
Is generic semaglutide safe?
A legally approved generic semaglutide can contain the same active pharmaceutical ingredient, but patients should verify the manufacturer’s product, regulatory status, formulation and storage requirements. Do not use an unknown or unlabelled injectable product.
Is Wegovy better than generic semaglutide?
It is more useful to compare the exact product, evidence, approved indication, device, dose, manufacturing quality, availability and cost rather than assuming that one brand is universally better. Your endocrinologist can select the formulation that fits your clinical situation.
Can semaglutide be used only for Weight Loss?
For people who meet the approved criteria for chronic Weight Management, a weight-management formulation may be prescribed. Semaglutide also has important Diabetes indications. The correct product depends on the diagnosis and approved indication.
Key Takeaways
- Semaglutide is a GLP-1 receptor agonist used for Type 2 Diabetes and, in appropriate formulations, chronic Weight Management.
- India now has multiple semaglutide brands following patent expiry and 2026 launches.
- Wegovy is the Novo Nordisk semaglutide product specifically used for chronic Weight Management.
- Ozempic and Rybelsus should not automatically be substituted for Wegovy simply because they contain semaglutide.
- Prices vary widely by brand, strength, formulation and pharmacy.
- Nausea, vomiting, diarrhea, constipation and abdominal symptoms are common, especially during dose escalation.
- Pancreatitis, gallbladder disease, dehydration/kidney injury and hypoglycemia in combination with certain diabetes medicines are important safety considerations.
- Do not change semaglutide brands or doses without medical supervision.
Medical Disclaimer
This article is for general educational purposes and does not replace an individualized medical consultation. Semaglutide is a prescription medicine. Do not start, stop, switch brands or change the dose without evaluation and advice from a qualified healthcare professional.
Sources
- Central Drugs Standard Control Organisation (CDSCO): Drug approval records
- Wegovy prescribing information
- CDC: Diabetes and related risk factors
- FDA: Concerns with unapproved GLP-1 drugs used for Weight Loss
Written and medically reviewed by Dr. Moxit Shah, DM Endocrinology.
